Source: International Congress 2019 – Mechanisms underlying acute exacerbation of respiratory disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Dickson (Ann Arbor, United States of America). Development and homeostasis of a healthy microbiome in the human respiratory tract. International Congress 2019 – Mechanisms underlying acute exacerbation of respiratory disease

Member's Comments

No comment yet.

Related content which might interest you: Sinecology of respiratory tract microflora Source: Annual Congress 2006 - Miscellaneous respiratory infections II Year: 2006 Targeting the microbiome in respiratory diseases Source: International Congress 2018 – Microbiomes in respiratory disease Year: 2018 Characterising the respiratory microbiome Source: Eur Respir J, 53 (2) 1801711; 10.1183/13993003.01711-2018 Year: 2019 Resilience of the nasopharyngeal microbiota following childhood lower respiratory tract infection Source: International Congress 2019 – Novel findings in paediatric respiratory infections Year: 2019 Characterization of the bacterial community within the respiratory tract of healthy mice; a molecular approach Source: Annual Congress 2008 - Best of lung epithelial cells 2008 Year: 2008 Nasal microbiota and symptom persistence in acute respiratory tract infections in infants Source: ERJ Open Res, 4 (4) 00066-2018; 10.1183/23120541.00066-2018 Year: 2018 Some aspects of mucosal immune response in children with bacterial upper respiratory tract infections Source: International Congress 2019 – New insights into childhood infections: from viral bronchiolitis to bronchiolitis obliterans Year: 2019 Age-associated change in respiratory microbiome architecture in healthy Singaporean subjects Source: International Congress 2019 – Bronchiectasis Year: 2019 Loss of microbial topography between oral and nasopharyngeal microbiota and development of respiratory infections early in life Source: International Congress 2019 – Novel findings in paediatric respiratory infections Year: 2019 The lung microbiome and its effects on respiratory infections Source: Virtual Congress 2020 – Respiratory infections Year: 2020 Role of α- and β-defensins in lower respiratory tract infections Source: Annual Congress 2007 - Aetiology, mechanisms and treatment in lower respiratory tract infections Year: 2007 Linking pathophysiology of lower respiratory tract infections with clinical expression Source: Annual Congress 2007 - PG24 - GRACE full-day course. From cough to asthma: the role of infection Year: 2007 Makrophages regulate epithelial defence of the respiratory tract Source: Annual Congress 2008 - Airway cell biology Year: 2008 Decreased innate immunity proteins in asthmatic respiratory tract lining fluids Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012 The role of the microbiome in the clinical management of respiratory infections Source: International Congress 2016 – Respiratory infections in high-income countries: old challenges and new threats Year: 2016 Expression and function of murine WFDC2 in the respiratory tract. Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020 Guidelines for the management of adult lower respiratory tract infections Source: Guideline 2005 Year: 2005 Guidelines for the management of adult lower respiratory tract infections Source: Eur Respir J 2005; 26: 1138-1180 Year: 2005 The microbiome in chronic respiratory diseases Source: International Congress 2017 – Can we translate the microbiome from basic science to clinical practice? Year: 2017 Respiratory tract infection in centenarians Source: Virtual Congress 2021 – Pneumonia Year: 2021